FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040573057> ?p ?o ?g. }

• W2040573057 endingPage "759" @default.
• W2040573057 startingPage "750" @default.
• W2040573057 abstract "Radiolabeled cyclic RGD (Arg-Gly-Asp) peptides represent a new class of radiotracers with potential for early tumor detection and noninvasive monitoring of tumor metastasis and therapeutic response in cancer patients. This article describes the synthesis of two cyclic RGD peptide dimer conjugates, DOTA-PEG4-E[PEG4-c(RGDfK)]2 (DOTA-3PEG4-dimer: DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; PEG4 = 15-amino-4,7,10,13-tetraoxapentadecanoic acid) and DOTA-G3-E[G3-c(RGDfK)]2 (DOTA-3G3-dimer: G3 = Gly-Gly-Gly). Integrin αvβ3 binding affinities of cyclic RGD peptides were determined by competitive displacement of 125I-echistatin bound to U87MG human glioma cells and follow the order of DOTA-E{E[c(RGDfK)]2}2 (DOTA-tetramer: IC50 = 10 ± 2 nM) > DOTA-3G3-dimer (IC50 = 62 ± 6 nM) ∼ DOTA-3PEG4-dimer (IC50 = 74 ± 3 nM) > DOTA-E[c(RGDfK)]2 (DOTA-dimer: IC50 = 102 ± 5 nM). The addition of PEG4 and G3 linkers between two cyclic RGD motifs in DOTA-3G3-dimer and DOTA-3PEG4-dimer makes it possible for them to achieve the simultaneous integrin αvβ3 binding in a bivalent fashion. Both 64Cu(DOTA-3PEG4-dimer) and 64Cu(DOTA-3G3-dimer) were prepared in high yield with specific activity being >50 Ci/mmol. Biodistribution and imaging studies were performed in athymic nude mice bearing U87MG human glioma xenografts. The results from those studies show that PEG4 and G3 linkers are particularly useful for improving tumor uptake and clearance kinetics of 64Cu radiotracers from the nontumor organs, such as kidneys, liver, and lungs. There is a linear relationship between the tumor size and %ID tumor uptake, suggesting that 64Cu(DOTA-3PEG4-dimer) and 64Cu(DOTA-3PEG4-dimer) might be useful for noninvasive monitoring of tumor growth or shrinkage during antiangiogenic therapy. MicroPET imaging data clearly demonstrate the utility of 64Cu(DOTA-3G3-dimer) as a new PET radiotracer for imaging integrin αvβ3-positive tumors." @default.
• W2040573057 created "2016-06-24" @default.
• W2040573057 creator A5000979147 @default.
• W2040573057 creator A5018249388 @default.
• W2040573057 creator A5022600083 @default.
• W2040573057 creator A5041589562 @default.
• W2040573057 creator A5066431767 @default.
• W2040573057 creator A5075403741 @default.
• W2040573057 date "2009-03-25" @default.
• W2040573057 modified "2023-09-27" @default.
• W2040573057 title "Improving Tumor Uptake and Pharmacokinetics of ⁶⁴Cu-Labeled Cyclic RGD Peptide Dimers with Gly₃ and PEG₄ Linkers" @default.
• W2040573057 cites W140814971 @default.
• W2040573057 cites W147592962 @default.
• W2040573057 cites W1495287184 @default.
• W2040573057 cites W1794577973 @default.
• W2040573057 cites W1964695532 @default.
• W2040573057 cites W1965384612 @default.
• W2040573057 cites W1975799575 @default.
• W2040573057 cites W1986818072 @default.
• W2040573057 cites W1990801388 @default.
• W2040573057 cites W2000000541 @default.
• W2040573057 cites W2000459976 @default.
• W2040573057 cites W2000799481 @default.
• W2040573057 cites W2001573485 @default.
• W2040573057 cites W2004182520 @default.
• W2040573057 cites W2006710254 @default.
• W2040573057 cites W2008769552 @default.
• W2040573057 cites W2016618261 @default.
• W2040573057 cites W2018159680 @default.
• W2040573057 cites W2020318021 @default.
• W2040573057 cites W2022554522 @default.
• W2040573057 cites W2024846013 @default.
• W2040573057 cites W2025894222 @default.
• W2040573057 cites W2028459481 @default.
• W2040573057 cites W2029773366 @default.
• W2040573057 cites W2030811592 @default.
• W2040573057 cites W2033301436 @default.
• W2040573057 cites W2036460471 @default.
• W2040573057 cites W2039317622 @default.
• W2040573057 cites W2046200653 @default.
• W2040573057 cites W2051802363 @default.
• W2040573057 cites W2053356946 @default.
• W2040573057 cites W2055322648 @default.
• W2040573057 cites W2058418451 @default.
• W2040573057 cites W2062711801 @default.
• W2040573057 cites W2064278400 @default.
• W2040573057 cites W2065246138 @default.
• W2040573057 cites W2065977830 @default.
• W2040573057 cites W2068812502 @default.
• W2040573057 cites W2074707269 @default.
• W2040573057 cites W2079309670 @default.
• W2040573057 cites W2080656565 @default.
• W2040573057 cites W2084238159 @default.
• W2040573057 cites W2088056286 @default.
• W2040573057 cites W2094931890 @default.
• W2040573057 cites W2096377687 @default.
• W2040573057 cites W2101281436 @default.
• W2040573057 cites W2102158108 @default.
• W2040573057 cites W2104293722 @default.
• W2040573057 cites W2120172300 @default.
• W2040573057 cites W2121521155 @default.
• W2040573057 cites W2136209423 @default.
• W2040573057 cites W2155707671 @default.
• W2040573057 cites W2163830997 @default.
• W2040573057 cites W22785605 @default.
• W2040573057 cites W2461642981 @default.
• W2040573057 cites W2775580218 @default.
• W2040573057 cites W4240248079 @default.
• W2040573057 cites W4250428608 @default.
• W2040573057 doi "https://doi.org/10.1021/bc800455p" @default.
• W2040573057 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2676896" @default.
• W2040573057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19320477" @default.
• W2040573057 hasPublicationYear "2009" @default.
• W2040573057 type Work @default.
• W2040573057 sameAs 2040573057 @default.
• W2040573057 citedByCount "120" @default.
• W2040573057 countsByYear W20405730572012 @default.
• W2040573057 countsByYear W20405730572013 @default.
• W2040573057 countsByYear W20405730572014 @default.
• W2040573057 countsByYear W20405730572015 @default.
• W2040573057 countsByYear W20405730572016 @default.
• W2040573057 countsByYear W20405730572017 @default.
• W2040573057 countsByYear W20405730572018 @default.
• W2040573057 countsByYear W20405730572019 @default.
• W2040573057 countsByYear W20405730572020 @default.
• W2040573057 countsByYear W20405730572021 @default.
• W2040573057 countsByYear W20405730572022 @default.
• W2040573057 countsByYear W20405730572023 @default.
• W2040573057 crossrefType "journal-article" @default.
• W2040573057 hasAuthorship W2040573057A5000979147 @default.
• W2040573057 hasAuthorship W2040573057A5018249388 @default.
• W2040573057 hasAuthorship W2040573057A5022600083 @default.
• W2040573057 hasAuthorship W2040573057A5041589562 @default.
• W2040573057 hasAuthorship W2040573057A5066431767 @default.
• W2040573057 hasAuthorship W2040573057A5075403741 @default.
• W2040573057 hasBestOaLocation W20405730572 @default.
• W2040573057 hasConcept C178790620 @default.
• W2040573057 hasConcept C185592680 @default.

• next